BR9807100A - Benzo[e]isoindóis e benzo[h]isoquinolinas tricìclicos - Google Patents

Benzo[e]isoindóis e benzo[h]isoquinolinas tricìclicos

Info

Publication number
BR9807100A
BR9807100A BR9807100-9A BR9807100A BR9807100A BR 9807100 A BR9807100 A BR 9807100A BR 9807100 A BR9807100 A BR 9807100A BR 9807100 A BR9807100 A BR 9807100A
Authority
BR
Brazil
Prior art keywords
disorders
benzo
isoindoles
isoquinolines
stroke
Prior art date
Application number
BR9807100-9A
Other languages
English (en)
Inventor
Michael Boes
Heinz Stadler
Juergen Wichmann
Original Assignee
Hoffamann La Roche Ag F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffamann La Roche Ag F filed Critical Hoffamann La Roche Ag F
Publication of BR9807100A publication Critical patent/BR9807100A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/62—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Patente de Invenção: <B>"BENZO[E]ISOINDóIS E BENZO[H]SOQUINOLINAS TRICìCLICOS"<D>. A presente invenção refere-se a novas benzo[e]-isoindóis e benzo[h]isoquinolinas. Uma vez que os compostos de acordo com a invenção podem ligar-se a receptores de serotonina (5HT~ 2~), eles são especialmente adequados para o tratameno ou prevenção de distúbios nervosos centrais tais como depressões, distúrbios bipolares, estados de ansiedade, distúbios do sono e sexual, psicose, esquizofrenia, enxaqueca e outras condições associadas com dor cefálica ou dor de uma espécie dirente, distúrbios de personalidade ou distúbios compulsivos obsessivos, fobias sociais ou ataques de pânico, distúrbios orgânicos mentais, distúrbios menstais na infância, agressividade, distúrbios da memória relacionados com a idade e distúrbios de comportamento, vício, obesidade, bulimia, etc., dano do sistema nervoso causado por trauma, acidente vascular cerebral, doenças neurodegenerativas, etc.; distúrbios cardiovasculares, tais como hipertensão, trombose, acidente vascular cerebral, etc; e distúrbios gastrintestinais tais como disfunção da motilidade do trato gastrintestinal.
BR9807100-9A 1997-01-08 1998-01-07 Benzo[e]isoindóis e benzo[h]isoquinolinas tricìclicos BR9807100A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97100172 1997-01-08
PCT/EP1998/000043 WO1998030546A1 (en) 1997-01-08 1998-01-07 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES

Publications (1)

Publication Number Publication Date
BR9807100A true BR9807100A (pt) 2000-04-25

Family

ID=26145159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807100-9A BR9807100A (pt) 1997-01-08 1998-01-07 Benzo[e]isoindóis e benzo[h]isoquinolinas tricìclicos

Country Status (9)

Country Link
EP (1) EP0958285B1 (pt)
JP (1) JP3297058B2 (pt)
AT (1) ATE257470T1 (pt)
AU (1) AU742735B2 (pt)
BR (1) BR9807100A (pt)
CA (1) CA2276098C (pt)
DE (1) DE69820989T2 (pt)
DK (1) DK0958285T3 (pt)
WO (1) WO1998030546A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010073153A (ko) 1998-09-18 2001-07-31 제임스 에이. 아노 녹내장 치료용의 세로토닌성 5ｈｔ2 작용제
US6780862B2 (en) 2000-12-20 2004-08-24 Bristol-Myers Squibb Pharma Company Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
JP2004115510A (ja) * 2002-09-05 2004-04-15 Toray Fine Chemicals Co Ltd ピペラジン誘導体の製造方法
WO2006022420A1 (ja) 2004-08-25 2006-03-02 Takeda Pharmaceutical Company Limited 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
EP1796663B1 (en) * 2004-09-03 2011-05-04 Athersys, Inc. Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
UA95641C2 (en) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN100402534C (zh) * 2006-11-09 2008-07-16 东南大学 一种三环类化合物及其在制药中的应用
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH504438A (de) * 1968-05-27 1971-03-15 Sandoz Ag Verfahren zur Herstellung von 1,2,3,4,4a,5,6,10b-Octahydrobenz(h)isochinolin-6-on
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression
US5180733A (en) * 1990-03-30 1993-01-19 Abbott Laboratories Biogenic amine uptake inhibitors

Also Published As

Publication number Publication date
JP2000507965A (ja) 2000-06-27
DK0958285T3 (da) 2004-05-17
EP0958285B1 (en) 2004-01-07
WO1998030546A1 (en) 1998-07-16
DE69820989D1 (de) 2004-02-12
AU5986698A (en) 1998-08-03
AU742735B2 (en) 2002-01-10
EP0958285A1 (en) 1999-11-24
DE69820989T2 (de) 2004-12-09
JP3297058B2 (ja) 2002-07-02
CA2276098C (en) 2007-05-08
ATE257470T1 (de) 2004-01-15
CA2276098A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
CA2153937A1 (en) Tricyclic pyrazole derivatives
CA2132887A1 (en) Tricyclic 1-aminoethylpyrrole-derivatives
BR9807100A (pt) Benzo[e]isoindóis e benzo[h]isoquinolinas tricìclicos
BR0309303A (pt) Moduladores de receptores de 5ht2c
RU94037964A (ru) Производные 1-амино-этилиндола
BRPI0515528A (pt) n-metil hidroxietilamina úteis no tratamento de condições do sistema nervoso central
ATE349211T1 (de) Dual bindende acetylcholinesterase inhibitoren zur behandlung von alzheimer
WO2006019886A3 (en) Pyrrolo(oxo)isoquinolines as 5ht ligands
DE69929464D1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
PE20010575A1 (es) Derivados de indol y su uso como ligandos del receptor 5ht2
TR199901586T2 (xx) Trisiklik benzo[e] izoindoller ve benzo[h] izokinolinler
ATE279418T1 (de) Antidepressive indoltetrahydropyridin-derivate von 2,3-dihydro-7h(1,4)dioxino(2,3-e)indol
DE60213576D1 (de) ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN
ECSP982363A (es) BENZO (e) ISOINDOLES TRICICLICOS Y BENZO (h)ISOQUINOLINAS
ES2183092T3 (es) Proceso para la preparacion de iohexol cristalino purificado.
DE60004473D1 (de) Verwendung von gaba-b rezeptor liganden zur herstellungen von medikamenten zur behandlung von neurodegenerativen erkrankungen
ATE287404T1 (de) Diazabicyclo (2.2.1) heptanderivate
CR7203A (es) 5-sustituidas-2-arilpiridinas como moduladores del factor 1 de liberacion de corticotropina
RU2003126422A (ru) Спсооб лечения сладж-синдрома у больных хроническим бекскаменным холецистиом

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM O ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.